1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Predictive Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Cancer
  • 1.2.3 Neurological Disorder
  • 1.2.4 Cardiovascular Disorder
  • 1.2.5 Immunological Disorder
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Predictive Biomarkers Market Share by Application: 2020 VS 2026
  • 1.3.2 Diagnostic Centers
  • 1.3.3 Academic Research Institutes
  • 1.3.4 CRO’S
  • 1.3.5 Bio-Pharmaceutical Companies
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Predictive Biomarkers Market Perspective (2015-2026)
• 2.2 Global Predictive Biomarkers Growth Trends by Regions
  • 2.2.1 Predictive Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Predictive Biomarkers Historic Market Share by Regions (2015-2020)
  • 2.2.3 Predictive Biomarkers Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Predictive Biomarkers Players by Market Size
  • 3.1.1 Global Top Predictive Biomarkers Players by Revenue (2015-2020)
  • 3.1.2 Global Predictive Biomarkers Revenue Market Share by Players (2015-2020)
• 3.2 Global Predictive Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Predictive Biomarkers Revenue
• 3.4 Global Predictive Biomarkers Market Concentration Ratio
  • 3.4.1 Global Predictive Biomarkers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Predictive Biomarkers Revenue in 2019
• 3.5 Key Players Predictive Biomarkers Area Served
• 3.6 Key Players Predictive Biomarkers Product Solution and Service
• 3.7 Date of Enter into Predictive Biomarkers Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Predictive Biomarkers Breakdown Data by Type (2015-2026)

• 4.1 Global Predictive Biomarkers Historic Market Size by Type (2015-2020)
• 4.2 Global Predictive Biomarkers Forecasted Market Size by Type (2021-2026)

5 Predictive Biomarkers Breakdown Data by Application (2015-2026)

• 5.1 Global Predictive Biomarkers Historic Market Size by Application (2015-2020)
• 5.2 Global Predictive Biomarkers Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Predictive Biomarkers Market Size (2015-2026)
• 6.2 North America Predictive Biomarkers Market Size by Type (2015-2020)
• 6.3 North America Predictive Biomarkers Market Size by Application (2015-2020)
• 6.4 North America Predictive Biomarkers Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Predictive Biomarkers Market Size (2015-2026)
• 7.2 Europe Predictive Biomarkers Market Size by Type (2015-2020)
• 7.3 Europe Predictive Biomarkers Market Size by Application (2015-2020)
• 7.4 Europe Predictive Biomarkers Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Predictive Biomarkers Market Size (2015-2026)
• 8.2 China Predictive Biomarkers Market Size by Type (2015-2020)
• 8.3 China Predictive Biomarkers Market Size by Application (2015-2020)
• 8.4 China Predictive Biomarkers Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Predictive Biomarkers Market Size (2015-2026)
• 9.2 Japan Predictive Biomarkers Market Size by Type (2015-2020)
• 9.3 Japan Predictive Biomarkers Market Size by Application (2015-2020)
• 9.4 Japan Predictive Biomarkers Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Predictive Biomarkers Market Size (2015-2026)
• 10.2 Southeast Asia Predictive Biomarkers Market Size by Type (2015-2020)
• 10.3 Southeast Asia Predictive Biomarkers Market Size by Application (2015-2020)
• 10.4 Southeast Asia Predictive Biomarkers Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Siemens Healthcare
  • 11.1.1 Siemens Healthcare Company Details
  • 11.1.2 Siemens Healthcare Business Overview
  • 11.1.3 Siemens Healthcare Predictive Biomarkers Introduction
  • 11.1.4 Siemens Healthcare Revenue in Predictive Biomarkers Business (2015-2020))
  • 11.1.5 Siemens Healthcare Recent Development
• 11.2 Roche Diagnostic
  • 11.2.1 Roche Diagnostic Company Details
  • 11.2.2 Roche Diagnostic Business Overview
  • 11.2.3 Roche Diagnostic Predictive Biomarkers Introduction
  • 11.2.4 Roche Diagnostic Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.2.5 Roche Diagnostic Recent Development
• 11.3 G.E. Healthcare
  • 11.3.1 G.E. Healthcare Company Details
  • 11.3.2 G.E. Healthcare Business Overview
  • 11.3.3 G.E. Healthcare Predictive Biomarkers Introduction
  • 11.3.4 G.E. Healthcare Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.3.5 G.E. Healthcare Recent Development
• 11.4 Abbott Laboratories
  • 11.4.1 Abbott Laboratories Company Details
  • 11.4.2 Abbott Laboratories Business Overview
  • 11.4.3 Abbott Laboratories Predictive Biomarkers Introduction
  • 11.4.4 Abbott Laboratories Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.4.5 Abbott Laboratories Recent Development
• 11.5 Qiagen
  • 11.5.1 Qiagen Company Details
  • 11.5.2 Qiagen Business Overview
  • 11.5.3 Qiagen Predictive Biomarkers Introduction
  • 11.5.4 Qiagen Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.5.5 Qiagen Recent Development
• 11.6 Johnson and Johnson
  • 11.6.1 Johnson and Johnson Company Details
  • 11.6.2 Johnson and Johnson Business Overview
  • 11.6.3 Johnson and Johnson Predictive Biomarkers Introduction
  • 11.6.4 Johnson and Johnson Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.6.5 Johnson and Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Predictive Biomarkers Scope and Market Size
Predictive Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Predictive Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others

Market segment by Application, split into
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies

Based on regional and country-level analysis, the Predictive Biomarkers market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Predictive Biomarkers market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
...